Eli Lilly and Company (LLY): Price and Financial Metrics


Eli Lilly and Company (LLY)

Today's Latest Price: $190.77 USD

4.08 (2.19%)

Updated Jan 15 7:00pm

Add LLY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

LLY Stock Summary

  • With a market capitalization of $178,584,218,531, ELI LILLY & Co has a greater market value than 98.94% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 11.39 for ELI LILLY & Co; that's greater than it is for 94.43% of US stocks.
  • The volatility of ELI LILLY & Co's share price is greater than that of just 5.67% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ELI LILLY & Co are ORCL, CSCO, NVO, TXN, and SAP.
  • LLY's SEC filings can be seen here. And to visit ELI LILLY & Co's official web site, go to www.lilly.com.

LLY Stock Price Chart Interactive Chart >

Price chart for LLY

LLY Price/Volume Stats

Current price $190.77 52-week high $191.78
Prev. close $186.69 52-week low $117.06
Day low $186.80 Volume 6,624,500
Day high $191.78 Avg. volume 5,249,360
50-day MA $157.68 Dividend yield 1.55%
200-day MA $153.75 Market Cap 182.49B

Eli Lilly and Company (LLY) Company Bio


Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company was founded in 1876 and is based in Indianapolis, Indiana.


LLY Latest News Stream


Event/Time News Detail
Loading, please wait...

LLY Latest Social Stream


Loading social stream, please wait...

View Full LLY Social Stream

Latest LLY News From Around the Web

Below are the latest news stories about ELI LILLY & Co that investors may wish to consider to help them evaluate LLY as an investment opportunity.

Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

Yahoo | January 15, 2021

Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals

Lilly's (LLY) candidate, donanemab shows slowing of cognitive decline in Alzheimer's disease patients. Novartis (NVS) and Sanofi (SNY) announce M&A deals.

Yahoo | January 15, 2021

Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund

Eli Lilly and Company (NYSE: LLY) today announced a $30 million limited partner investment in Unseen Capital Health Fund LP, a newly-formed venture fund created by racially diverse and historically underrepresented business leaders that is intended to identify, fund and support underrepresented founders of early-stage healthcare companies and those building solutions for marginalized communities. The $30 million investment by Lilly is a component of the company's racial justice efforts and provides mission-aligned capital for the Fund. Unseen Capital is now active and investing, and with Lilly's investment, is well on its way to achieving its target of $100 million.

Yahoo | January 15, 2021

Radiopharmaceutical Market to Watch: Spotlight on SIEMENS, Jubilant Pharma, Eli Lilly, GE Healthcare

Global Radiopharmaceutical Industry Market Research Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis,

OpenPR | January 14, 2021

Biogen Stock Is Jumping Because There May Be Hope for Its Alzheimer’s Drug Yet

Investors have had a rough time betting on aducanumab— Biogen’s experimental treatment for Alzeheimer’s disease.

Yahoo | January 14, 2021

Read More 'LLY' Stories Here

LLY Price Returns

1-mo 11.30%
3-mo 35.69%
6-mo 19.29%
1-year N/A
3-year 138.61%
5-year 164.05%
YTD 12.99%
2020 31.04%
2019 16.14%
2018 40.45%
2017 17.83%
2016 -10.37%

LLY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LLY Dividend History

Continue Researching LLY

Want to see what other sources are saying about ELI LILLY & Co's financials and stock price? Try the links below:

ELI LILLY & Co (LLY) Stock Price | Nasdaq
ELI LILLY & Co (LLY) Stock Quote, History and News - Yahoo Finance
ELI LILLY & Co (LLY) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8945 seconds.